China is already the fastest growing market in the world for pharmaceuticals. Now, after billions of dollars of government and private investment, China is transforming itself into a world leader in biotechnology.

ChinaBio® Today focuses exclusively on the rapidly evolving biotech and life science industry in China. From our offices in Shanghai, San Diego and Palo Alto, California, we provide daily news, commentary and analysis on public and private China biotech companies and industry events, as well as global issues affecting the China market.

Our parent organization, ChinaBio® LLC, provides advisory services to leading investment organizations and biotechnology companies involved in the China biotech industry, including Roche, Pfizer, Genentech, Humana and others.  We also provide funding and guidance to promising early stage China biotechs through, ChinaBio® Accelerator (www.ChinaBioLLC.com), which also conducts seminars, road shows and forums, such as our annual ChinaBio® Investor Forum (www.CBIF2008-BJ.com) and ChinaBio® Executive Workshops (www.ChinaBio-CBEW.com.  

Publisher and Executive Editor: Greg B. Scott
Business Editor: Richard Daverman, PhD

Read more about Our Approach, Our Editors and Our Sponsors below...

In This Category

• Our Approach
• Our Editors
• Our Partners